Nexalin Technology, Inc. (NXL) vs 60 Degrees Pharmaceuticals, Inc. (SXTP)
A side-by-side comparison of Nexalin Technology, Inc. and 60 Degrees Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NXL
Nexalin Technology, Inc.
$4.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SXTP
60 Degrees Pharmaceuticals, Inc.
$1.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — NXL vs SXTP
growth of $100 · dividends reinvested · last 3yNXL -78.3% (-39.9%/yr)SXTP -99.9% (-89.1%/yr)NXL compounded faster over this window
Log scale — wide-divergence pair
NXL SXTP
NXL vs SXTP: by the numbers
- •SXTP is the larger company ($4M vs $3M market cap).
- •Both run net losses; SXTP's is the smaller (-730.23% vs -4139.38% net margin).
- •NXL grew revenue faster over the past five years (10.22% vs -14.35% CAGR).
Metrics side by side
Valuation
| Metric | NXL | SXTP |
|---|---|---|
| P/S ratio | 15.20 | 3.51 |
| P/B ratio | 2.17 | N/A |
Profitability
| Metric | NXL | SXTP |
|---|---|---|
| Gross margin | 79.65% | 19.42% |
| Operating margin | -2781.69% | -774.90% |
| Net margin | -4139.38% | -730.23% |
| ROE | -591.60% | -310.33% |
| ROIC | -600.62% | -321.28% |
Growth (annualized)
| Metric | NXL | SXTP |
|---|---|---|
| Revenue CAGR (5Y) | 10.22% | -14.35% |
Frequently asked
- Which has grown faster, NXL or SXTP?
- Over the past five years, NXL grew revenue faster — NXL at a 10.22% CAGR versus SXTP at -14.35%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.